Universidade Federal de São Paulo

Running trials

• Recruiting

  Multiple Interventions With Distinct Anti-reservoir Activities in People on Antiretroviral Treatment

  NCT07903441· Phase 2· Federal University of São Paulo· Source

• Recruiting

  Safety and Potency of a High Cabergoline Dosage in Microprolactinomas

  NCT07463235· Phase 3· University of Sao Paulo General Hospital· Source

• Recruiting

  Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation

  NCT05723926· Javelin Medical· Source

• Not yet recruiting

  Intra-articular Infiltration of Platelet-Rich Fibrin vs Corticosteroid in Mild to Moderate Knee Osteoarthritis

  NCT06905860· Phase 4· Federal University of São Paulo· Source

• Active, not recruiting

  An Adapted Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Familial Hypercholesterolemia (DICA-FH)

  NCT06331195· Hospital do Coracao· Source

• Recruiting

  MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  NCT06152575· Phase 3· Pfizer· Source

• Active, not recruiting

  Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma (JLS)

  NCT07908108· Istituto Giannina Gaslini· Source

• Active, not recruiting

  Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

  NCT05317416· Phase 3· Pfizer· Source

• Recruiting

  A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

  NCT05020236· Phase 3· Pfizer· Source

• Active, not recruiting

  Triplenex (triple Fixed Combination) Use Evaluation in Patients with Glaucoma

  NCT06761313· Phase 4· Federal University of São Paulo· Source

• Active, not recruiting

  Transfemoral Implant of Inovare® Transcatheter Valve

  NCT05531578· Braile Biomedica Ind. Com. e Repr. Ltda.· Source

• Recruiting

  A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

  NCT03773965· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Randomization of Single vs Multiple Arterial Grafts

  NCT03217006· Weill Medical College of Cornell University· Source

• Recruiting

  Treatment of Brain AVMs (TOBAS) Study

  NCT02098252· Centre hospitalier de l'Université de Montréal (CHUM)· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke2 recruiting
• Atrial fibrillation1 recruiting
• Coronary artery disease1 recruiting
• HIV1 recruiting
• Multiple myeloma1 recruiting
• Osteoarthritis1 recruiting
• Pituitary tumours1 recruiting
• Psoriatic arthritis1 recruiting

Closed trials

• Completed

  Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)

  NCT06122961· Novo Nordisk A/S· Source

• Completed

  Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

  NCT05834738· Phase 2· Novartis Pharmaceuticals· Source

• Completed

  Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

  NCT05536297· Phase 3· Astellas Pharma Global Development, Inc.· Source

• Completed

  Resistance Profile to Antiretroviral Medications in Individuals Living With HIV Who Failed a First-Line Regimen With Tenofovir / Lamivudina and Dolutegravir in Brasil

  NCT07618507· Federal University of São Paulo· Source

• Terminated

  A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome

  NCT05163314· Phase 3· Takeda· Source

• Completed

  Methylene Blue for the Prevention of Hypotension During Hemodialysis

  NCT05092165· Phase 2· Federal University of São Paulo· Source

• Completed

  Rostock International Parkinson's Disease Study (ROPAD)

  NCT03866603· CENTOGENE GmbH Rostock· Source

• Completed

  Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial

  NCT02699645· Phase 3· The George Institute· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Obesity128 works · 0 trials
• Chronic kidney disease58 works · 1 trial
• Glaucoma54 works · 1 trial
• Melanoma51 works · 0 trials
• Obstructive sleep apnoea49 works · 0 trials
• Insomnia38 works · 0 trials
• Diabetic eye disease36 works · 0 trials
• Schizophrenia32 works · 0 trials
• Deep vein thrombosis and pulmonary embolism30 works · 0 trials
• Lupus (SLE)29 works · 0 trials
• Hearing loss21 works · 0 trials
• Keratoconus19 works · 0 trials
• Macular degeneration19 works · 1 trial
• Congenital heart disease15 works · 0 trials
• Endometriosis12 works · 0 trials
• Hydrocephalus11 works · 0 trials
• Childhood cancers11 works · 0 trials
• Chronic spontaneous urticaria10 works · 0 trials
• Ankylosing spondylitis9 works · 0 trials
• Dystonia9 works · 0 trials
• Long COVID and ME/CFS9 works · 0 trials
• Retinitis pigmentosa8 works · 0 trials
• Fibromyalgia7 works · 0 trials
• Sarcoidosis7 works · 0 trials
• Primary biliary cholangitis6 works · 0 trials
• Restless legs syndrome6 works · 0 trials
• High blood pressure5 works · 2 trials
• Hyperparathyroidism5 works · 0 trials
• Narcolepsy4 works · 0 trials
• Fabry disease4 works · 0 trials